What is Sunrise?
Founded in 2015, Sunrise has established itself as a leader in sleep health technology. The company's flagship innovation is an FDA-cleared mandibular movement sensor, a sophisticated at-home diagnostic device designed for sleep apnea. This technology has garnered validation through peer-reviewed studies and endorsements from prominent sleep experts, positioning Sunrise at the forefront of accessible and effective sleep disorder diagnostics. The company's focus on developing validated, user-friendly devices addresses a critical unmet need in the healthcare market.
How much funding has Sunrise raised?
Sunrise has raised a total of $82M across 4 funding rounds:
Other Financing Round
$18M
Other Financing Round
$6M
Unspecified
$29M
Other Financing Round
$29M
Other Financing Round (2023): $18M with participation from Sambrinvest, Kurma Partners, and Namur Invest
Other Financing Round (2023): $6M led by UI Investissement
Unspecified (2025): $29M supported by Kurma Partners, Eurazeo, Vives, and WE International
Other Financing Round (2025): $29M featuring Eurazeo, WE International, Vives, and Kurma Partners
Key Investors in Sunrise
Kurma Partners
Kurma Partners is a European investment firm specializing in healthcare and biotechnology innovation, providing capital from pre-seed to growth stages. They focus on unmet medical needs and innovative biotech/medtech companies.
Eurazeo
Eurazeo is a global investment company with expertise in private equity, venture capital, real estate, and private debt, supporting companies of all sizes in their development and growth.
Vives
VIVES is a multi-sector investment fund focused on innovative business projects with societal impact, investing in spin-offs and startups from universities and research institutions.
What's next for Sunrise?
With the recent major strategic investment, Sunrise is poised for significant expansion. The capital injection will likely fuel further research and development into advanced sleep monitoring solutions, potentially broadening their product portfolio and enhancing existing technologies. Strategic partnerships and market penetration efforts are anticipated as the company leverages this funding to solidify its position as a key player in the global sleep health industry. The company's trajectory suggests a move towards scaling operations and increasing market reach.
See full Sunrise company page
